Dr. Hope on the Future of Imaging for Biochemical Recurrent Prostate Cancer

Thomas Hope, MD
Published: Thursday, Nov 09, 2017



Thomas Hope, MD, assistant professor of abdominal imaging and nuclear medicine at University of California, San Francisco (UCSF), discusses the future of imaging for biochemical recurrent prostate cancer.

Hope says that it is important to understand how novel imaging techniques such as PSMA-PET effect care by including them in clinical trials, as well as demonstrating when they should be used.
 
SELECTED
LANGUAGE


Thomas Hope, MD, assistant professor of abdominal imaging and nuclear medicine at University of California, San Francisco (UCSF), discusses the future of imaging for biochemical recurrent prostate cancer.

Hope says that it is important to understand how novel imaging techniques such as PSMA-PET effect care by including them in clinical trials, as well as demonstrating when they should be used.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
35th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® Clinical Vignette SeriesJan 31, 20192.0
Oncology Briefings™: Current Perspectives on Preventing and Managing Tumor Lysis SyndromeJun 30, 20191.0
Publication Bottom Border
Border Publication
x